vimarsana.com
Home
Live Updates
Q32 Bio Presents New Preclinical Data at the International S
Q32 Bio Presents New Preclinical Data at the International S
Q32 Bio Presents New Preclinical Data at the International Society of Nephrology Frontiers Meeting Demonstrating the Therapeutic Potential of ADX-097
/PRNewswire/ -- Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, today announced that the...
Related Keywords
Italy ,
Stefan Wawersik ,
Shelia Violette ,
Sarah Sutton ,
Brendan Burns ,
International Society Of Nephrology ,
Directed Factorh Targeting Delivers Potent ,
Durable Complement Inhibition ,
Disease Modifying Efficacy ,
Skin Without Inhibiting Systemic Complement ,
International Society ,
Chief Scientific Officer ,
Passive Heymann ,
Q32 Bio ,